ArticleDermatology and therapy2023

Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629.

Åse Bratland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.